echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Teyi Pharmaceutical: Pyrazinamide tablets passed the consistency evaluation of generic drugs

    Teyi Pharmaceutical: Pyrazinamide tablets passed the consistency evaluation of generic drugs

    • Last Update: 2021-10-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 8, Teyi Pharmaceuticals issued an announcement stating that the company had recently obtained the "Pyrazinamide Tablets" "Drug Supplementary Application Approval Notice" approved and issued by the National Medical Products Administration.


    Pyrazinamide tablets are anti-tuberculosis drugs that can be combined with other anti-tuberculosis drugs (such as streptomycin, isoniazid, rifampicin and ethambutol) for the treatment of tuberculosis


    Pyrazinamide tablets are among the national essential drugs, the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Catalogue (2020 Edition)" Class A drugs, the first-line anti-tuberculosis drugs recommended by the World Health Organization (WHO), and the standard treatment for anti-tuberculosis treatment Basic drugs, according to the fourth edition of the "Guidelines for the Treatment of Tuberculosis" issued by the WHO Department of Tuberculosis Prevention and Treatment in 2010, the standard treatment plan for new patients is 2HRZE/4HR (H: Isoniazid; R: Rifampicin; Z: Pyrazinamide; E: Ethambutol)


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.